Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (Pap-Op): Prospective Assessment of HPV Associated Anogenital Pathology


About this study

The purpose of this study is to determine the incidence of anogenital infection with high-risk HPV serotypes and HPV-associated anogenital lesions in female patients with newly diagnosed HPV(+)OPSCC and female partners of patients with HPV(+)OPSCC, and compare this with retrospective review of exams and paps obtained during routine well woman checks in Rochester MN.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester.
  • Age ≥ 18.
  • Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC.
  • Patient has given permission to give his/her blood/saliva sample for research testing.
  • Ability to complete questionnaire(s) by themselves or with assistance. [LMM1] I.

Exclusion Criteria

  • HPV(-) OPSCC.
  • Unable to provide informed consent.
  • Unwilling to attend screening visit at Mayo. Clinic site, if indicated.
  • Unwilling/unable to complete surveys electronically.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 4/28/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kathryn Van Abel, M.D.

Open for enrollment

Contact information:

Dante Merlino M.D., Ph.D.


More information


Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions